HPV Message Testing and Social Media Campaign

Human Papilloma Virus Clinical Trial

Official title:

HPV Message Testing and Social Media Campaign

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03747302
• Other study ID #: D18180
• Secondary ID: 3P30CA023108-38S
• Status: Completed
• Phase: N/A
• Start date: December 12, 2018
• Est. completion date: September 9, 2019

Study information

• Verified date: August 2022
• Source: Dartmouth-Hitchcock Medical Center
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This project involves a social media campaign to increase parent's knowledge and acceptance of the HPV (human papillomavirus) vaccine. The current vaccine protects against nine types of HPV, including seven that are known to cause cancer. The Centers for Disease Control and Prevention (CDC) estimates that the current HPV vaccine could prevent 90% of cancer cases caused by HPV, including cases of cervical cancer, oropharyngeal (mouth and throat) cancer, anal cancer, and others. About 150 and 104 cases of HPV-associated cancers are diagnosed each year in New Hampshire and Vermont, respectively-many of which could be prevented through vaccination. Currently, only 49.8% of New Hampshire adolescents and 44.3% of Vermont adolescents were not up-to-date for HPV vaccination as of 2016. This social media campaign is testing a set of campaign messages with parents locally and nationally to see which messages are most effective in improving their knowledge and acceptance of the vaccine. A study survey link will monitor the number of people reached and will measure parental intention to get their children vaccinated against HPV.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 1043
• Est. completion date: September 9, 2019
• Est. primary completion date: September 9, 2019
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• parents of children 9-14 years old

Exclusion Criteria:

• non-parents

Related Conditions & MeSH terms

• Human Papilloma Virus
• Papilloma
• Vaccine

Intervention

Other:
• Social Media Message about HPV and HPV vaccine
Messages educate parents with facts about HPV vaccination.
• Social media message about risk of electronic cigarettes.
Messages educate parents with facts about electronic cigarettes. This is an attention control group without outcomes obtained.

Locations

Country	Name	City	State
United States	Dartmouth-Hitchcock Medical Center	Lebanon	New Hampshire

Sponsors (3)

Lead Sponsor	Collaborator
Dartmouth-Hitchcock Medical Center	National Cancer Institute (NCI), Norris Cotton Cancer Center

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change in Attitudes About HPV Vaccine	Change in Attitudes about HPV vaccine: Pre to post test comparison of summated 9 items measured on a 7-point scale of HPV vaccine attitudes. Scores range from a minimum of 9 to a maximum of 63. Higher scores indicated more positive attitudes toward HPV vaccination. Change was calculated from two time points, the later time point(<1 hour post messaging intervention) minus value at baseline.	Post test completed < 1 hour post messaging intervention
Secondary	Behavioral Intention to Vaccinate Their Child With HPV Vaccine	A sub-group of parents of 9-14 year old children who had not been vaccinated were asked on pre- and post-test: How likely is it that she/he will receive the HPV vaccine in the next 12 months? Responses range form 1 (very likely) to 5 (not very likely).; HPV vaccination behavioral intent change scores were calculated by subtracting pre- and post- test values. It is a negative-value scale, in which smaller values indicate more positive attitude change after exposure to the viewed message.	Ore test immediately before viewing message and post- test immediately after viewing message. Approximately one hour.

External Links

•   HPV cancer diagnosis rates
•   HPV cancer diagnosis rates
•   HPV vaccination rates